title: [Choroidal tuberculoma in a patient with acquired immunodeficiency syndrome].
abstract: BACKGROUND
  In Japan, since the introduction of antituberculosis chemotherapy, the typical choroidal tuberculoma has been considered uncommon. A patient with acquired immunodeficiency syndrome (AIDS), because of the suppression of cell mediated immunity, faces the risk of tuberculous infection.
  
  
  METHODS
  A 30-year-old Malayan man had continuous cough for six months. He was diagnosed as having miliary tuberculosis of the lung and spine. Because the serum test of human immunodeficiency virus (HIV) was positive, he was also diagnosed as having AIDS.
  
  
  RESULTS
  Fundus examination showed a yellow white swollen lesion of the choroid with distinct border in his right eye, probably caused by tuberculosis. After three months of therapy with antituberculosis and anti HIV drugs, his systemic and ocular findings were markedly improved.
  
  
  CONCLUSIONS
  Because of the recent increase in the incidence of tuberculosis with the epidemic of HIV prevailing in the world, the recognition of ocular tuberculosis is important.
authors.affiliation: Department of Ophthalmology, Tokyo Women's Medical University, School of Medicine, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Shimakawa
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D002829:Choroid; D006801:Humans; D007111:Immunity, Cellular; D016867:Immunocompromised Host; D008297:Male; D012306:Risk; D016896:Treatment Outcome; D014391:Tuberculosis, Miliary / Q000188:drug therapy / Q000209:etiology; D014392:Tuberculosis, Ocular / Q000188:drug therapy / Q000209:etiology*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000209:etiology; D014399:Tuberculosis, Spinal / Q000188:drug therapy / Q000209:etiology
chemical_list: D019380:Anti-HIV Agents; D000995:Antitubercular Agents